Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Finorga was a prominent French contract development and manufacturing organization (CDMO) specializing in the production of active pharmaceutical ingredients (APIs) and fine chemicals. The company was globally recognized for its advanced expertise in chiral technologies, including asymmetric synthesis and industrial-scale chromatography. Operating primarily from its facility in Mourenx, France, Finorga served the pharmaceutical industry by providing complex multi-step chemical synthesis from pilot to commercial scale. It was particularly noted for its pioneering work in Simulated Moving Bed (SMB) chromatography for the separation of enantiomers. In 2004, the company was acquired by Novasep, and following subsequent mergers, its operations are now part of the Axplora group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Finorga.